Terray Therapeutics Closes Oversubscribed $120M Series B to Advance Its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic
Financing will also expand Terray’s integrated AI platform, tNova. Financing brings total equity financing since inception to over $200 million. October 17, 2024 09:00 AM Eastern Daylight Time LOS ANGELES–(BUSINESS WIRE)–Terray Therapeutics, a biotechnology company…